PTPN22 and lymphoma: To deeply discover new markers related to the etiology, progression and prognosis of lymphoma, we used the Agena Massarray technology platform to detect 25 candidate SNPs of 21 genes (TNFA, IFNG, IFNL3, IL2, IL4, IL6R, IL9, IL10, IL12A, IL22, TGFB1, TBX21/TBET, STAT1, STAT3, STAT5B, STAT6, GATA3, NFKBIA, ITGAM, PTPN22, PARP1) in 245 lymphoma patients and 213 healthy controls.8, 10, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57